Mpox: A Global Health Challenge – Understanding the Current Outbreak & Future Risks
Did You Know? While often referred to as ‘monkeypox’, the World Health Organization (WHO) officially renamed the disease ‘mpox‘ in November 2023 to combat stigma and provide a more accurate, less discriminatory name.
Mpox, a viral disease historically confined to parts of Central and West Africa, is now a notable global health concern. Ten months after the WHO declared it a Public Health Emergency of International Concern (PHEIC), the virus continues to spread, impacting both African nations and increasingly, countries worldwide. Understanding the current state of the mpox outbreak – its spread, severity, and evolving control measures – is crucial for individuals, healthcare professionals, and policymakers alike. This article provides a comprehensive overview of the situation as of mid-2025, drawing on the latest data and expert insights.
The Expanding Geographic Footprint of Mpox
Between January 2024 and May 2025, a concerning 139,333 suspected mpox cases were reported across 26 African countries. Of these, 34,824 were laboratory-confirmed, tragically resulting in 1,788 deaths among suspected cases and 186 deaths among confirmed cases1,2. This data underscores the continued severity of the outbreak, especially within Africa.
Though, the story isn’t solely confined to the continent. 2025 has witnessed a worrying expansion of the geographic reach of mpox. Six African nations – Ethiopia, Malawi, Sierra Leone, South Sudan, tanzania, and Togo – reported cases for the first time. Together, the virus has crossed continents, with initial cases identified in china, switzerland, and the United Arab Emirates.Perhaps most concerning is the re-emergence of mpox in countries previously considered to have contained the outbreak, including Angola, Ghana, morocco, and South Africa. This resurgence highlights the challenges of sustained control and the potential for ongoing transmission.
Pro Tip: Staying informed about local and global mpox updates is vital.regularly check the WHO website (https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON384) and your national health authority for the latest guidance and recommendations.
Positive Trends & Effective Control Measures
Despite the expanding geographic spread, there’s a glimmer of hope. Epidemiological data from Burundi, the Democratic Republic of Congo (DRC), and Uganda – the three countries most heavily affected – indicate a sustained decline in both case incidence and mortality rates. This suggests that targeted local control measures are proving effective. these measures likely include:
Enhanced Surveillance: Improved detection and reporting of cases.
Vaccination campaigns: Targeted vaccination programs, particularly for high-risk populations. (See section below on vaccine availability)
Public Health Education: Raising awareness about transmission routes, symptoms, and preventative measures.
Contact Tracing: Identifying and monitoring individuals who have been in contact with confirmed cases.
Isolation & Supportive Care: Providing appropriate medical care and isolating infected individuals to prevent further spread.
However, it’s crucial to remember that these positive trends are localized. The overall global situation remains precarious, and complacency could quickly reverse these gains.
Understanding Mpox Transmission & Symptoms
Mpox is caused by the mpox virus, a member of the orthopoxvirus family – the same family that includes the variola virus (which causes smallpox). Transmission occurs through:
Direct Contact: With the rash, scabs, or body fluids of an infected person or animal.
Respiratory Secretions: Through prolonged face-to-face contact.
Contaminated Materials: Touching items (clothing, bedding, etc.) that have been in contact with an infected person or animal.
* Vertical Transmission: From mother to fetus during pregnancy.
Symptoms typically begin with a fever, headache, muscle aches, and swollen lymph nodes. This is followed by the characteristic rash, which progresses through several stages: macules (flat spots), papules (raised bumps), vesicles
Related reading